Dementia Prevention by Stroke Prevention

Stroke and dementia are among the leading causes of disability and impairment of quality of life in old age. Vascular diseases are the second most common cause of dementia after Alzheimer's disease, and often contribute to the development of primary neurodegenerative dementias. While therapeutic breakthroughs in the neurodegenerative causes of dementia are still pending, improvements in vascular prevention and stroke treatment offer new and effective approaches to the prevention of dementia.

October 13, 2018, 10:00am - 5:00pm
Kosmos, Karl-Marx-Allee 131a, 10243 Berlin, Germany
Open for all

Hosts: Center for Stroke Research Berlin, CompetenceNet Stroke, Institute for Stroke and Dementia Research (ISD), German Center for Neurodegenerative Diseases, NeuroCure Cluster of Excellence, SyNerg - Munich Dluster for Systems Neurology


10:00 - Setting the Scene

Chairs: Vladimir Hachinski – London, Ontario, Canada | Karl Max Einhäupl - Charité-Universitätsmedizin Berlin, Germany

  • Dementia prevention by stroke prevention: call for action
    Vladimir Hachinski – London, Ontario, Canada
  • Dementia in aging societies and opportunities for prevention
    Carol Brayne – Cambridge Institute of Public Health, UK
  • Diverging trends in dementia
    Suvarna Alladi – National Institute of Mental Health and Neurosciences, Bengaluru, India

11:20 - Coffee Break

11:40 - Now is the time

Chairs: Martin Dichgans – Ludwig-Maximilians Universität München, Germany | Matthias Endres – Charité-Universitätsmedizin Berlin, Germany

  • Less dementia with oral anticoagulation in atrial fibrillation
    Leif Friberg – Karolinska Institute, Stockholm, Sweden
  • Post-Stroke Dementia: mechanisms and opportunities for prevention
    Martin Dichgans – Ludwig-Maximilians Universität München, Germany
  • Vascular dysregulation: A Key Triggering Factor of Late Onset Alzheimer's Disease
    Yasser Iturria Medina – Montreal Neurological Institute and Hospital, Canada

13:00 - Lunch

14:00 - Targets for Dementia Prevention: Vessels and Molecules

Chairs: Ulrich Dirnagl – Charité-Universitätsmedizin Berlin, Germany | Arno Villringer – Max Planck Institute for Human Cognitive and Brain Sciences, Leipzig, Germany

  • Cerebral amyloid angiopathy as a target for dementia prevention
    Steven Greenberg – Harvard Medical School, Boston, USA
  • The vascular biology of dementia
    Costantino Iadecola – Cornell University, New York, USA
  • Cerebral small vessel disease: novel targets for prevention
    Joanna Wardlaw – UK Dementia Research Institute, University of Edinburgh, UK

15:20 - Coffee Break

15:40 - Roadmap for Dementia Prevention

Chairs: Zaven Khachaturian – Editor-in-chief, Alzheimer & Dementia | Brian Rowe – University of Alberta, Canada

  • Facilitating research for dementia prevention: the German Center for Neurodegenerative Diseases
    Pierluigi Nicotera – German Center for Neurodegenerative Diseases, Bonn, Germany
  • Action Plan for Stroke in Europe
    Bo Norrving – Lund University, Sweden
  • Turning knowledge into action: lessons from stroke
    Werner Hacke – University of Heidelberg, Germany
  • Next steps and concluding remark
    Zaven Khachaturian – Editor-in-chief, Alzheimer & Dementia